Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited. A study published in Biosafety and Health prospectively followed four LTx recipients. Clinical characteristics, ...
Oct 24, 2023
0
0
Antiviral drugs are generally considered to be a 20th century invention. But recent research has uncovered an unexpected facet to your immune system: It can synthesize its own antiviral molecules in response to viral infections.
Oct 11, 2023
0
1
A new study has demonstrated rapid and sensitive on-site detection of SARS-CoV-2 RNA from environmental surfaces using a portable laboratory device. The study was published in Microbiology Spectrum.
Oct 4, 2023
0
26
HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops. These reservoirs have long been thought to be dormant, ...
Sep 13, 2023
0
48
New UC Riverside research has revealed COVID's Achilles heel—its dependence on key human proteins for its replication—which can be used to prevent the virus from making people sick.
Sep 13, 2023
0
237
COVID patients exhale high numbers of virus during the first eight days after symptoms start, as high as 1,000 copies per minute, reports a new Northwestern Medicine study.
Sep 11, 2023
1
3
A microbiologist, who was involved in the first study to witness human-to-human COVID transmission, is among experts laying out strategies that would help the world react and prepare for the next pandemic.
Sep 6, 2023
0
1
Researchers from Trinity have discovered some new and surprising ways that viral RNA and influenza virus are detected by human lung cells, which has potential implications for treating people affected by such viruses.
Aug 31, 2023
0
6
Immediately after the infection of a cell in the throat or lungs, the SARS-CoV-2 virus works very hard to replicate, using the human cell's metabolic pathways to produce its proteins and make sure that its genetic material ...
Aug 21, 2023
0
28
Research led by the Walter Reed Army Institute of Research, Maryland, has confirmed previous research findings of host restriction factors that target HIV-1. In a paper, "Single-cell transcriptomics identifies prothymosin ...
